Nymox Pharmaceutical (NYMXF) Change in Accured Expenses (2021 - 2022)
Nymox Pharmaceutical's Change in Accured Expenses came in at $732,000 for Q1 2022, compared with -$677,000 a year earlier.
Powered by 
Analysis
Nymox Pharmaceutical (NYMXF) Change in Accured Expenses (2021 - 2022) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accured Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 1.20 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 901.00 Mn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 338.00 Mn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | - |
| 10 | Nymox Pharmaceutical | 3.84 Mn | 3.65 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2022 | 732,000.00 |
| Mar 31, 2021 | -677,000.00 |
API Access
Nymox Pharmaceutical Change in Accured Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NYMXF&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "NYMXF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=NYMXF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();